MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

City of Hope, Duarte, California, United States

University of California, Los Angeles (UCLA), Santa Monica, California, United States

Sarah Cannon Research Institute at HealthOne, Denver, Colorado, United States

Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando, Florida, United States

Emory University School of Medicine, Atlanta, Georgia, United States

Community Health Network, Indianapolis, Indiana, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan, United States

New York University (NYU) Langone Medical Center, New York, New York, United States

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States

Duke University Medical Center, Durham, North Carolina, United States

University of Cincinnati (UC) - Cancer Institute, Cincinnati, Ohio, United States

Cleveland Clinic, Cleveland, Ohio, United States

University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Sarah Cannon Research Institute, Nashville, Tennessee, United States

USO - US Oncology Research Network, Nashville, Tennessee, United States

Vanderbilt University School of Medicine, Nashville, Tennessee, United States

MD Anderson Cancer Center, Houston, Texas, United States

South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, United States

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Fred Hutchinson Cancer Center, Seattle, Washington, United States

University of Wisconsin - Carbone Cancer Center, Madison, Wisconsin, United States

The Ottawa Hospital, Ottawa, Canada

Princess Margaret Hospital, Toronto, Canada

Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, China

Beijing Cancer hospital, Beijing, China

Harbin Medical University Cancer Hospita, Harbin, China

Fudan University Cancer Center, Shanghai, China

Centre Leon Berard, Lyon, France

Centre d'Essais Precoces en Cancerologie de Marseille (CEPCM) - AP-HM Hopital de La Timone, Marseille, France

Oncopole Claudius Regaud, Toulouse, France

Institut Gustave Roussy, Villejuif, France

Charite Universitaetsmedizin Berlin, Berlin, Germany

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Germany

Universitaetsklinikum Essen, Essen, Germany

Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Germany

START Dublin Early Phase Clinical Trials Unit, Dublin, Ireland

Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli, Naples, Italy

UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Italy

Centro Ricerche Cliniche di Verona s.r.l., Verona, Italy

National Cancer Center Hospital East, Chiba, Japan

Kanagawa cancer center, Kanagawa, Japan

Aichi Cancer Center Hospital, Nagoya, Japan

Kansai Medical University Hospital, Osaka, Japan

National Cancer Center Hospital, Tokyo, Japan

South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos, Barcelona, Spain

Hospital Universitario Vall d'Hebron, Barcelona, Spain

South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid, Spain

Hospital Universitario 12 de Octubre, Madrid, Spain